A type of drug used to treat patients with movement disorders appears to cause unusual sexual urges and other erratic behaviors, while pharmaceutical firm GSK has known about the side effects for over two decades without explicitly warning patients, according to a news report from the United Kingdom.
A Monday report from the BBC revealed that the British news outlet obtained documents from GSK showing the company knew of “deviant” sexual behavior associated with dopamine agonist drugs like Ropinirole.
Yet the company does not make explicit warnings about the behaviors clear on drug pamphlets, according to the BBC, which said they only generally warn about heightened libido and possible harmful behavior.
Trending: DOGE Makes Another Bombshell Discovery
The drugs work by mimicking dopamine, a pleasure hormone natural to the body, but
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!